HKEX opportunity knocking
Jefferies’ Brinkman weighs in on the new HKEX biotech chapter
The rapid growth of biotech in the greater China region is something Jefferies does not intend to miss.
With the opening of a new biotech chapter on the Hong Kong Exchanges and Clearing Ltd. on April 30, the bank’s small team in China is now focused primarily on HKEX listings, according to investment banker Michael Brinkman...